Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Go back to Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST| APTARGROUP, Inc. (NYSE: ATR) | Delayed: 121.78 -0.33 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $122.11 | 52 Week High | $81.50 | |||
| Open | $122.05 | 52 Week Low | $66.33 | |||
| Day High | $122.47 | P/E | 48.33 | |||
| Day Low | $120.74 | EPS | $2.52 | |||
| Volume | 185,665 | |||||
| (NASDAQ: MIST) | Delayed: 1.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.07 | 52 Week High | $ | |||
| Open | $1.07 | 52 Week Low | $ | |||
| Day High | $1.08 | P/E | N/A | |||
| Day Low | $1.06 | EPS | $ | |||
| Volume | 624,134 | |||||
